pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·5h ago·1 min read
save

Mass General and Dana-Farber CEOs receive record compensation in 2024 amid hospital cost pressures

Aug 18, 2026·read at STAT ↗Negative

Newly released compensation records show that chief executives of major Massachusetts health systems earned substantially higher pay in 2024.

Dr. Anne Klibanski, the CEO of Mass General Brigham, topped the list as the highest‑paid health‑system executive in the state.

The raises came as hospitals grappled with rising post‑pandemic expenses, thin operating margins and the statewide disruption following the collapse of Steward Health Care, prompting analysts to say the increases reflect market rates for senior leaders.

David E. Williams, president of Health Business Group, noted that attracting talent in a national market is the primary driver behind the higher salaries for these complex organizations.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Leaders of Mass General, Dana-Farber among hospital execs who got big raises in 2024”

read at STAT ↗
421 words · retrieved 5h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING2
topics
Oncology2NSCLCPulmonology

related stories

  • 14h agoHow health care costs are undermining America’s public-sector employersSTAT
  • Aug 3BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotechBioSpace
  • Aug 3BlossomHill eyes $112M IPO harvest to bankroll potential Tagrisso challengerFierce Biotech
  • May 29STAT+: Up and down the ladder: The latest comings and goingsSTAT
  • May 6Clinical Scenario Presentation and Treatment Approach for Progressive Diseaseonclive